Figure 2. Survivals of patients with MLL-PTD AML.
Kaplan-Meier estimates of A. event-free survival and B. overall survival according to age, and C. event-free survival and D. overall survival according to the mutation status of DNMT3A in patients with MLL-PTD associated AML.